Morgan Stanley’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $18.8K | Hold |
|
|||||
|
2023
Q1 | $33.6K | Buy |
|
|||||
|
2022
Q4 | $31.6K | Buy |
|
|||||
|
2022
Q3 | $40K | Buy |
|
|||||
|
2022
Q2 | $28K | Sell |
|
|||||
|
2022
Q1 | $86K | Buy |
|
|||||
|
2021
Q4 | $87K | Sell |
|
|||||
|
2021
Q3 | $145K | Sell |
|
|||||
|
2021
Q2 | $120K | Buy |
|
|||||
|
2021
Q1 | $146K | Sell |
|
|||||
|
2020
Q4 | $253K | Buy |
|
|||||
|
2020
Q3 | $182K | Sell |
|
|||||
|
2020
Q2 | $277K | Buy |
|
|||||
|
2020
Q1 | $168K | Buy |
|
|||||
|
2019
Q4 | $155K | Buy |
|
|||||
|
2019
Q3 | $126K | Sell |
|
|||||
|
2019
Q2 | $160K | Buy |
|
|||||
|
2019
Q1 | $165K | Sell |
|
|||||
|
2018
Q4 | $193K | Sell |
|
|||||
|
2018
Q3 | $369K | Sell |
|
|||||
|
2018
Q2 | $524K | Buy |
|
|||||
|
2018
Q1 | $496K | Buy |
|
|||||
|
2017
Q4 | $370K | Buy |
|
|||||
|
2017
Q3 | $333K | Sell |
|
|||||
|
2017
Q2 | $1.02M | Buy |
|
|||||
|
2017
Q1 | $144K | Buy |
|
|||||
|
2016
Q4 | $24K | Sell |
|
|||||
|
2016
Q3 | $93K | Buy |
|
|||||
|
2016
Q2 | $22K | Sell |
|
|||||
|
2016
Q1 | $25K | Sell |
|
|||||
|
2015
Q4 | $1.04M | Sell |
|
|||||
|
2015
Q3 | $1.88M | Buy |
|
|||||
|
2015
Q2 | $10K | Buy |
|
|||||
|
2015
Q1 | $0 | Sell |
|
|||||
|
2014
Q4 | $1K | Sell |
|
|||||
|
2014
Q3 | $101K | Sell |
|
|||||
|
2014
Q2 | $159K | Buy |
|
|||||
|
2014
Q1 | $86K | Buy |
|
|||||
|
2013
Q4 | $50K | Sell |
|
|||||
|
2013
Q3 | $67K | Buy |
|